Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.7T | 1.7T | 1.7T | 1.6T |
Cost of revenue | 1.1T | 1.1T | 1.1T | 1.0T |
Gross profit | 582.2B | 576.5B | 593.8B | 616.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 42.2B | 53.5B | 45.7B | 40.8B |
Other operating expenses | 32.8B | 63.6B | 38.1B | 27.2B |
Operating income | 256.7B | 204.9B | 239.6B | 280.6B |
Non operating interest income | ||||
Income | 6.6B | 5.3B | 7.1B | 5.4B |
Expense | 55.9B | 54.6B | 49.1B | 36.9B |
Other income expense | — | — | — | — |
Pretax income | 214.8B | 142.8B | 208.1B | 251.2B |
Tax provision | 54.2B | 51.0B | 52.7B | 53.2B |
Net income | 160.6B | 91.8B | 155.5B | 198.0B |
Basic EPS | 8.4 | — | — | — |
Diluted EPS | 8.1 | — | — | — |
Basic average shares | 15.4B | — | — | — |
Diluted average shares | 15.4B | — | — | — |
EBITDA | 337.9B | 268.5B | 326.4B | 354.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -35.9B | -24.0B | -30.5B | -45.8B |
Preferred stock dividends | 0 | 0 | 0 | 0 |